Quo Vadis Advanced Prostate Cancer Therapy? Novel Treatment Perspectives and Possible Future Directions
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quo Vadis Advanced Prostate Cancer Therapy? Novel Treatment Perspectives and Possible Future Directions
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 8, Pages 2228
Publisher
MDPI AG
Online
2021-04-12
DOI
10.3390/molecules26082228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: 89Zr-Pt@TiO2-SPHINX, synthesis and in vitro evaluation
- (2021) Volkan Tekin et al. NUCLEAR MEDICINE AND BIOLOGY
- TALAPRO-1: A phase II study of talazoparib (TALA) in men with DNA damage repair mutations (DDRmut) and metastatic castration-resistant prostate cancer (mCRPC)—First interim analysis (IA).
- (2020) Johann S. De Bono et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective
- (2020) Lucie Peterková et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gold nanoparticle clusters for the investigation of therapeutic efficiency against prostate cancer under near-infrared irradiation
- (2020) Jeonghun Kim et al. Nano Convergence
- Clinical outcomes and markers of treatment response in a randomized phase II study of androgen deprivation therapy with or without palbociclib in RB-intact metastatic hormone-sensitive prostate cancer (mHSPC).
- (2020) Phillip Lee Palmbos et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergistic performance of triggered drug release and photothermal therapy of MCF7 cells based on laser activated PEGylated GO + DOX
- (2020) N. S. Hosseini Motlagh et al. Biomedical Optics Express
- Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
- (2020) Luca Braglia et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells
- (2020) Vy Anh Tran et al. International Journal of Nanomedicine
- Mitotic Poisons in Research and Medicine
- (2020) Jan Škubník et al. MOLECULES
- PARP Inhibitors in Metastatic Prostate Cancer: Evidence to Date
- (2020) Emily Nizialek et al. Cancer Management and Research
- Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)
- (2020) Simon J. Crabb et al. JOURNAL OF CLINICAL ONCOLOGY
- Large Scale Conversion of Trilobolide into the Payload of Mipsagargin: 8-O-(12-Aminododecanoyl)-8-O-Debutanoylthapsigargin
- (2020) Tomáš Zimmermann et al. Biomolecules
- Nanomaterial Applications in Photothermal Therapy for Cancer
- (2019) Austin Doughty et al. Materials
- Pamiparib, an investigational PARP inhibitor, in patients with metastatic castration-resistant prostate cancer (mCRPC) and a circulating tumor cell (CTC) homologous recombination deficiency (HRD) phenotype or BRCA defects: A trial in progress.
- (2019) Simon Chowdhury et al. JOURNAL OF CLINICAL ONCOLOGY
- Photothermal-Triggered Controlled Drug Release from Mesoporous Silica Nanoparticles Based on Base-Pairing Rules
- (2019) Xiaoting Li et al. ACS Biomaterials-Science & Engineering
- A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy
- (2019) Lei Qiang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
- (2019) Ardeshir R. Rastinehad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
- (2019) Meghan A. Rice et al. Frontiers in Oncology
- LBA50Pre-specified interim analysis of GALAHAD: A phase II study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD)
- (2019) M R Smith et al. ANNALS OF ONCOLOGY
- PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label single‐arm phase 2 study
- (2019) Daniel P. Petrylak et al. PROSTATE
- Light-Induced Therapies for Prostate Cancer Treatment
- (2019) Claudia Ferroni et al. Frontiers in Chemistry
- CAR-T cell therapy: a potential new strategy against prostate cancer
- (2019) Giuseppe Schepisi et al. Journal for ImmunoTherapy of Cancer
- Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
- (2018) A R Hansen et al. ANNALS OF ONCOLOGY
- Perspectives on the clinical development of immunotherapy in prostate cancer
- (2018) RaviA Madan et al. ASIAN JOURNAL OF ANDROLOGY
- Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions
- (2018) Catherine E Handy et al. Future Oncology
- Cotargeting AR signaling and cell cycle: A randomized phase II study of androgen deprivation therapy with or without palbociclib in RB-positive metastatic hormone sensitive prostate cancer (mHSPC).
- (2018) Phillip Lee Palmbos et al. JOURNAL OF CLINICAL ONCOLOGY
- A review of nanoparticle photosensitizer drug delivery uptake systems for photodynamic treatment of lung cancer
- (2018) Mpho Gift Mokwena et al. Photodiagnosis and Photodynamic Therapy
- Apalutamide for the treatment of prostate cancer
- (2018) Dana E. Rathkopf et al. Expert Review of Anticancer Therapy
- Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
- (2018) Johann S. de Bono et al. CLINICAL CANCER RESEARCH
- Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy
- (2017) Meike Adam et al. EUROPEAN UROLOGY
- Surgery-based Multimodal Management of High-risk Prostate Cancer Patients: What Is the Functional Price To Pay for Optimal Disease Control?
- (2017) Thomas Seisen et al. EUROPEAN UROLOGY
- Darolutamide (ODM-201) for the treatment of prostate cancer
- (2017) Neal D. Shore EXPERT OPINION ON PHARMACOTHERAPY
- Immunotherapy for Prostate Cancer: Where We Are Headed
- (2017) Giuseppe Schepisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Self-assembled albumin nanoparticles for combination therapy in prostate cancer
- (2017) Huibo Lian et al. International Journal of Nanomedicine
- Highly effective photothermal chemotherapy with pH-responsive polymer-coated drug-loaded melanin-like nanoparticles
- (2017) Chengwei Zhang et al. International Journal of Nanomedicine
- Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody
- (2017) Tadanobu Nagaya et al. MOLECULAR CANCER RESEARCH
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment
- (2017) Rachel S. Riley et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen
- (2016) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Combinations in multimodality treatments and clinical outcomes during cancer
- (2016) Xiao-Ying Zhang et al. Oncology Letters
- New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones
- (2015) AndrewV Schally et al. ASIAN JOURNAL OF ANDROLOGY
- Doxorubicin-loaded magnetic nanoparticle clusters for chemo-photothermal treatment of the prostate cancer cell line PC3
- (2015) Weibing Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Androgen Receptor Targeted Conjugate for Bimodal Photodynamic Therapy of Prostate Cancer in Vitro
- (2015) Valentina Rapozzi et al. BIOCONJUGATE CHEMISTRY
- Current approaches in SELEX: An update to aptamer selection technology
- (2015) Mariia Darmostuk et al. BIOTECHNOLOGY ADVANCES
- Initial Evaluation of the Safety of Nanoshell-Directed Photothermal Therapy in the Treatment of Prostate Disease
- (2015) Joshua M. Stern et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Trilobolide–porphyrin conjugates: On synthesis and biological effects evaluation
- (2015) Pavla Tomanová et al. STEROIDS
- Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure
- (2015) Abdel-Rahmene Azzouzi et al. WORLD JOURNAL OF UROLOGY
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
- (2015) Michal Podrazil et al. Oncotarget
- A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy
- (2015) Yang Liu et al. Theranostics
- Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies
- (2015) Anu-Maarit Moilanen et al. Scientific Reports
- Androgen-deprivation-associated bone disease
- (2014) Ted A. Skolarus et al. CURRENT OPINION IN UROLOGY
- Disease Control Outcomes from Analysis of Pooled Individual Patient Data from Five Comparative Randomised Clinical Trials of Degarelix Versus Luteinising Hormone-releasing Hormone Agonists
- (2014) Laurence Klotz et al. EUROPEAN UROLOGY
- High hydrostatic pressure induces immunogenic cell death in human tumor cells
- (2014) Jitka Fucikova et al. INTERNATIONAL JOURNAL OF CANCER
- PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways
- (2014) Carole Beck et al. NUCLEIC ACIDS RESEARCH
- TOOKAD®Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer
- (2013) Abdel-Rahmène Azzouzi et al. BJU INTERNATIONAL
- Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer
- (2013) Dana Rathkopf et al. CANCER JOURNAL
- Improved Survival in a Cohort of Trial Participants with Metastatic Castration-resistant Prostate Cancer Demonstrates the Need for Updated Prognostic Nomograms
- (2013) Aurelius Omlin et al. EUROPEAN UROLOGY
- Landmarks in hormonal therapy for prostate cancer
- (2012) Peter Hammerer et al. BJU INTERNATIONAL
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- (2012) N. J. Clegg et al. CANCER RESEARCH
- Evaluation of the Toxicity of Intravenous Delivery of Auroshell Particles (Gold–Silica Nanoshells)
- (2012) Shayne C. Gad et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Toward Maximizing Immunotherapy in Metastatic Castration-Resistant Prostate Cancer – Rationale for Combinatorial Approaches Using Chemotherapy
- (2012) Susan R. Slovin Frontiers in Oncology
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells
- (2011) A. G. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Contribution of the immune system to the chemotherapeutic response
- (2011) Alison M. McDonnell et al. Seminars in Immunopathology
- Multimodal approaches to high-risk prostate cancer
- (2010) A. Koupparis et al. Current Oncology
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
- (2010) Axel Heidenreich et al. EUROPEAN UROLOGY
- Nanodrug applications in photodynamic therapy
- (2010) Edyta Paszko et al. Photodiagnosis and Photodynamic Therapy
- Molecular and magnetic resonance imaging: The value of immunoliposomes
- (2009) Dorota Kozlowska et al. ADVANCED DRUG DELIVERY REVIEWS
- Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
- (2009) Yu Chen et al. LANCET ONCOLOGY
- In vitro targeted photodynamic therapy with a pyropheophorbide-a conjugated inhibitor of prostate-specific membrane antigen
- (2009) Tiancheng Liu et al. PROSTATE
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
- (2009) William P Harris et al. Nature clinical practice. Urology
- Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
- (2008) Gerhardt Attard et al. JOURNAL OF CLINICAL ONCOLOGY
- Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells
- (2008) Ira Skvortsova et al. PROTEOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search